Orexigen and Takeda Jointly Announce Orexigen's Acquisition of All Rights to CONTRAVE(R) in the United States

Acquisition provides Orexigen ownership of CONTRAVE in nearly all major global markets Takeda Moves to Strengthen Focus on Recent Launches SAN DIEGO and DEERFIELD, Ill., and OSAKA, Japan, March 15, 2016 -- (Healthcare Sales & Marketing Network) -- Ore... Biopharmaceuticals, AcquisitionsOrexigen Therapeutics, Takeda Pharmaceutical, CONTRAVE, naltrexone, bupropion
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news